NurExone Advances to Stage 2 of EU-Backed EIT Health Catapult Programme 2026

NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a biopharmaceutical company developing exosome-based regenerative therapies for central nervous system ...
The Chronicle of Philanthropy

Reinventing Program Officers: What Makes Them Effective Today

In years past, program officers put out RFPs, accepted applications and graded them, sent recommendations to foundation ...
Janes

Hanwha launches development of long-range air-to-air missile

Hanwha Aerospace is proceeding with the development of South Korea's long-range air-to-air missile (LRAAM), which is intended ...

Inside HUD: Essential Roles and Housing Programs

HUD is vital in enhancing homeownership and community development. Explore its programs like the Housing Choice Voucher and ...
The Motley Fool

Finally, Tesla Is Said to Be Developing an All-New SUV -- but That's Not the Biggest Surprise

Unnamed sources claim that Tesla is in discussions with suppliers about an all-new, smaller electric SUV. It's highly possible the all-new vehicle will be produced in China. The new vehicle will ...